Clinical Trial Update: PMZ-2010 (Centhaquine) as a Resuscitative Agent for Hypovolemic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of PMZ-2010 (Centhaquine) as a resuscitative agent for hypovolemic shock has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blood Loss
• Hypovolemic Shock

Drugs mentioned

• PMZ-2010 (Centhaquine) (Centhaquine)

Snippet

Sponsor: Pharmazz, Inc. | Conditions: Hypovolemic Shock, Blood Loss | Phase 2 | Status: COMPLETED